IL6 and colorectal cancer: Actually, CAF-derived IL-6 and JAK/STAT3 pathway have been demonstrated to involve in treatment resistance in multiple other cancers, including pancreatic cancer, cholangiocarcinoma, colorectal cancer and breast cancer28,49–51.